Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Allergan Is Dancing as Fast as It Can to Avoid Valeant Takeover with Salix Deal

Bill Ackman facebook

Allergan, which has received a well-storied hostile takeover bid from Valeant Pharmaceutical, courtesy of hedge fund manager Bill Ackman is making acquisitions to show it can perform well solo. Its next move is to acquire Salix Pharmaceuticals to ward off a $53 billion takeover bid from Valeant. However, people close to the matter say that negotiation talks are likely to break down between Salix and Allergan. The merger could be an act  of desperation, since Salix is valued at $10 billion and was up 16% on rumors of a takeover.

In addition, Allergan could be the target of another bid from Actavis, but since it has substantial debt, will be unlikely to take over the Botox maker. Allergan also has a shareholder meeting on December 18th, when the potential mergers can be voted on. Allergan has staunchly opposed mergers and stated its wish to remain independent.

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.